Sudden infant death syndrome: no increased risk after immunisation (Q34562321)

3 August 2017

title

Sudden infant death syndrome: no increased risk after immunisation (English)

1 reference

sudden infant death syndrome

3 August 2017

main subject

1 reference

8

E A Mitchell

1 reference

3 August 2017

M M T Vennemann

1

1 reference

3 August 2017

T Butterfass-Bahloul

2

1 reference

3 August 2017

G Jorch

3

1 reference

3 August 2017

B Brinkmann

4

1 reference

3 August 2017

M Findeisen

5

1 reference

3 August 2017

C Sauerland

6

1 reference

3 August 2017

T Bajanowski

7

1 reference

3 August 2017

GeSID Group

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

4 August 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

25

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

336-340

1 reference

The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Risk of sudden infant death syndrome after immunization with the diphtheria-tetanus-pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Sudden unexpected death in infants under 3 months of age and vaccination status- -a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Immunisation and the sudden infant death syndrome. New Zealand Cot Death Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Sudden and unexpected deaths after the administration of hexavalent vaccines (diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, Haemophilius influenzae type b): is there a signal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Unexplained cases of sudden infant death shortly after hexavalent vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Antivaccination activists on the world wide web

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

German study on sudden infant death (GeSID): design, epidemiological and pathological profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Modifiable risk factors for SIDS in Germany: results of GeSID.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Infection, health problems, and health care utilisation, and the risk of sudden infant death syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Whooping cough and unrecognised postperinatal mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

Risk factors for SIDS. Results of the National Institute of Child Health and Human Development SIDS Cooperative Epidemiological Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.027

10.1016/J.VACCINE.2006.07.027

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference